Edition:
India

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

36.83USD
15 Dec 2017
Change (% chg)

$-0.53 (-1.42%)
Prev Close
$37.36
Open
$37.36
Day's High
$37.36
Day's Low
$36.49
Volume
542,734
Avg. Vol
52,715
52-wk High
$42.00
52-wk Low
$19.34

Chart for

About

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone... (more)

Overall

Beta: --
Market Cap(Mil.): $1,304.09
Shares Outstanding(Mil.): 36.37
Dividend: --
Yield (%): --

Financials

BRIEF-Ascendis Pharma A/S Q3 loss per share EUR 1.04

* Ascendis Pharma A/S reports third quarter 2017 financial results

17 Nov 2017

BRIEF-Ascendis Pharma A/S prices public offering of 3.8 mln shares at $35.50 per ADS

* Ascendis Pharma A/S announces pricing of public offering of ADSs

27 Sep 2017

BRIEF-Ascendis Pharma A/S announces proposed public offering of ADSs

* Ascendis Pharma A/S announces proposed public offering of ADSs

27 Sep 2017

BRIEF-Ascendis Pharma A/S reports dosing of subjects in phase 1 trial of transcon pth

* Ascendis Pharma A/S announces dosing of subjects in phase 1 trial of Transcon pth

26 Sep 2017

BRIEF-Ascendis Pharma Q2 loss per share EUR 0.94

* Ascendis Pharma A/S reports second quarter 2017 financial results

18 Aug 2017

Earnings vs. Estimates